Evolus Non Recurring vs Other Operating Expenses Analysis
EOLS Stock | USD 13.04 0.41 3.25% |
Evolus financial indicator trend analysis is much more than just examining Evolus Inc latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Evolus Inc is a good investment. Please check the relationship between Evolus Non Recurring and its Other Operating Expenses accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evolus Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
Non Recurring vs Other Operating Expenses
Non Recurring vs Other Operating Expenses Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Evolus Inc Non Recurring account and Other Operating Expenses. At this time, the significance of the direction appears to have pay attention.
The correlation between Evolus' Non Recurring and Other Operating Expenses is -0.89. Overlapping area represents the amount of variation of Non Recurring that can explain the historical movement of Other Operating Expenses in the same time period over historical financial statements of Evolus Inc, assuming nothing else is changed. The correlation between historical values of Evolus' Non Recurring and Other Operating Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Recurring of Evolus Inc are associated (or correlated) with its Other Operating Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Operating Expenses has no effect on the direction of Non Recurring i.e., Evolus' Non Recurring and Other Operating Expenses go up and down completely randomly.
Correlation Coefficient | -0.89 |
Relationship Direction | Negative |
Relationship Strength | Significant |
Non Recurring
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Evolus Inc. It is also known as Evolus overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Most indicators from Evolus' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Evolus Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evolus Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. At this time, Evolus' Tax Provision is comparatively stable compared to the past year. Sales General And Administrative To Revenue is likely to gain to 0.91 in 2024, whereas Issuance Of Capital Stock is likely to drop 0.00 in 2024.
Evolus fundamental ratios Correlations
Click cells to compare fundamentals
Evolus Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Evolus fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 240.4M | 209.1M | 257.5M | 178.0M | 189.0M | 190.3M | |
Short Long Term Debt Total | 96.5M | 138.3M | 74.7M | 73.2M | 126.5M | 103.1M | |
Other Current Liab | 17.4M | 95.0M | 49.0M | 34.9M | 30.2M | 28.6M | |
Total Current Liabilities | 24.4M | 180.2M | 57.7M | 46.5M | 48.3M | 61.0M | |
Total Stockholder Equity | (213.1M) | (376.1M) | (422.9M) | 18.5M | (20.7M) | (21.7M) | |
Other Liab | 59.1M | 58.1M | 44.5M | 39.9M | 45.9M | 46.9M | |
Net Tangible Assets | (1.4M) | (149.5M) | 10.0M | (51.3M) | (59.0M) | (62.0M) | |
Net Debt | (13.3M) | 35.8M | (71.5M) | 19.3M | 63.7M | 66.9M | |
Retained Earnings | (213.1M) | (376.1M) | (422.9M) | (497.3M) | (559.0M) | (531.0M) | |
Accounts Payable | 5.8M | 9.6M | 6.1M | 8.9M | 4.3M | 4.9M | |
Cash | 109.9M | 102.6M | 146.3M | 53.9M | 62.8M | 70.0M | |
Non Current Assets Total | 88.2M | 81.5M | 78.7M | 77.2M | 76.6M | 63.4M | |
Common Stock Shares Outstanding | 28.2M | 33.7M | 49.8M | 56.1M | 56.9M | 37.9M | |
Liabilities And Stockholders Equity | (52.1M) | (94.0M) | (247.3M) | 178.0M | 189.0M | 198.4M | |
Non Current Liabilities Total | 136.5M | 101.8M | 117.9M | 113.0M | 161.4M | 94.2M | |
Other Current Assets | 5.3M | 11.8M | 16.1M | 5.6M | 8.1M | 6.4M | |
Other Stockholder Equity | (7K) | 303.1M | 504.8M | 516.1M | 538.7M | 272.4M | |
Total Liab | 161.0M | 282.0M | 175.6M | 159.5M | 209.7M | 178.1M | |
Total Current Assets | 152.2M | 127.6M | 178.8M | 100.8M | 112.4M | 103.1M | |
Intangible Assets | 59.6M | 55.3M | 50.6M | 48.6M | 47.1M | 43.2M | |
Non Currrent Assets Other | 2.4M | 240K | 2.8M | 2.8M | 409K | 388.6K | |
Other Assets | 2.4M | 3.7M | 32.5M | 2.8M | 1.0 | 0.95 | |
Net Invested Capital | 170.9M | 61M | 153.1M | 90.4M | 99.7M | 92.8M | |
Net Working Capital | 127.8M | (52.6M) | 121.1M | 54.3M | 64.1M | 41.5M | |
Long Term Debt | 91.5M | 40.5M | 71.2M | 71.9M | 120.4M | 75.6M | |
Cash And Short Term Investments | 129.8M | 107.6M | 146.3M | 53.9M | 62.8M | 79.1M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Evolus Stock Analysis
When running Evolus' price analysis, check to measure Evolus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolus is operating at the current time. Most of Evolus' value examination focuses on studying past and present price action to predict the probability of Evolus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolus' price. Additionally, you may evaluate how the addition of Evolus to your portfolios can decrease your overall portfolio volatility.